Business UpdateJun 5, 2026, 04:31 PM
DBV Technologies to Participate in Goldman Sachs Healthcare Conference
AI Summary
DBV Technologies announced that its Chief Executive Officer, Daniel Tassé, will participate in a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference. The event is scheduled for June 9, 2026, at 9:20 AM ET, and a live webcast will be available. The company is a late-stage biopharmaceutical firm developing treatments for food allergies using its VIASKIN® patch technology.
Key Highlights
- DBV Technologies CEO Daniel Tassé will participate in a fireside chat.
- The event is the Goldman Sachs 47th Annual Global Healthcare Conference.
- The fireside chat is scheduled for Tuesday, June 9, 2026, at 9:20 AM ET.
- A live webcast will be available, with an archived replay for 90 days.
- DBV Technologies is a late-stage biopharmaceutical company focused on food allergies.
Price Impact
More from DBVT